
Nano-X Imaging (NASDAQ:NNOX) Shares Tumble After Q2 Revenue and Profit Miss
Nano-X Imaging shares drop after Q2 revenue and profit miss estimates, hit by impairment charge and lower cash balance.
10 items · search:archive
Daily average lexicon sentiment across 202 scored headlines over the last 8 days. For market-wide mood (VIX, breadth, regime), see Markets. For the learned model that predicts forward return from a headline, see Headline Forecast Model.

Nano-X Imaging shares drop after Q2 revenue and profit miss estimates, hit by impairment charge and lower cash balance.

Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call September 9, 2026 8:30 AM EDTCompany ParticipantsMike CavanaughErez Meltzer - CEO & Acting Chairman of...

LOS ANGELES, CA - September 8, 2026 (NEWMEDIAWIRE) - Nanox (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., entered into a distribution agreement with Associated X-Ray Imaging Corp. to support deployment of the Nanox.ARC across Ne...

Expands Nanox’s growing U.S. distribution network with a leading New England-based medical imaging provider PETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its U.S.-based subsidiary, Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp., a New England-based provider of medical imaging equipment and services, specializing in X-

LOS ANGELES, CA - August 27, 2026 (NEWMEDIAWIRE) - Nanox (NASDAQ: NNOX), an innovative medical imaging technology company, announced it will report financial results for the quarter ended June 30, 2026, before market open on Sept. 9, 2026. CEO and Ac...

The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform spanning scan, analysis and interpretation. Nanox is expanding its commercial reach th...

PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2026, before market open on Monday, September, 9, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Guy Nathanzon, Chief Financial Officer, will host a conference call to review these results and provide a business update beg

Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced its subsidiary, Nanox AI Ltd. (“Nanox AI”) entered into a sales reseller agreement with Vertec Scientific Ltd. (“Vertec”) for the commercialization of Nanox.AI bone solution (HealthOST) in the United Kingdom. The agreement grants Vertec an exclusive license to mar
Nanox Imaging Ltd. ("Nanox", or the "Company" NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced its subsidiary, Nanox AI Ltd. ("Nanox AI") entered into a sales
Cantor Fitzgerald analyst Sarah James reiterates Nano X Imaging (NASDAQ:NNOX) with a Overweight and maintains $5 price target.